PP 1.4 – 00037 Histone decrotonylation uniquely regulates HIV-1 transcription and can be modulated to control HIV-1 latency von Simermeyer, T.L., Li, D., Wong, L.M., Aquino, C., Tang, Y., Browne, E.P., Archin, N.M., Margolis, D.M., Jiang, G.

Volltext

PP 2.9 – 00125 Impact of latency reversal agents on estrogen receptor alpha gene and protein expression von Ceriani, C., Lemu, K.L., Abeyta-Lopez, A., Allard, B., James, K.S., Margolis, D.M., Archin, N.M.

Volltext

OP 1.4 – 00053 Definitive evidence of a persistent HIV reservoir in human brain myeloid cells despite ART von Tang, Y., Jiang, G., Porrachia, M., Ignacio, C., Wong, L.M., Zhong, D., Du, J., Cotsakis, B., Maske, S., de la Parra Polina, E., Simermeyer, T.L., Li, D., Woodworth, B., Kirchherr, J., Allard, B., Clohosey, M., Whitehill, G.D., Eron, J.J., Archin, N.M., Joseph, S.B., Bar, K., Chaillon, A., Gianella, S., Margolis, D.M., Jiang, G.

Volltext

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy von Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., Richman, D. D., Hudgens, M. G., Bosch, R. J., Coffin, J. M., Eron, J. J., Hazuda, D. J., Margolis, D. M.

Volltext

The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection von Gay, C., Kuruc, J.D., Falcinelli, S.D., Warren, J., Kirchherr, J.L., Sholtis, K., Allard, B., Stuelke, E., Gamble, A., Plachco, A., Tcherapanova, I., Eron, J.J., Goonetilleke, N., DeBenedette, M., Nicolette, C.A., Archin, N.M., Margolis, D.M.

Volltext

Induction of HIV from latency by a novel molecule von Archin, N.M., Boden, D., Kirchherr, J., Allard, B., Sholtis, K., Kuruc, J.D., Kraus, G., Margolis, D.M.

Volltext

Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5 von Bosque, A., Macedo, A., Spivak, A., Novis, C.L., Martins, L.J., Szaniawski, M., Archin, N.M., Luciw, P.A., Margolis, D.M., Planelles, V.

Volltext

Combination therapy with the broadly neutralizing antibody VRC07-523LS and the latency reversal agent Vorinostat fails to substantially reduce latent, resting CD4+ T cell infection... von Margolis, D.M, James, K.S, Tuyishime, M, Falcinelli, S.D, Joseph, S.B, Allard, B, Kirchherr, J.L, Clohosey, M, Gorelick, R.J, Gama, L, Koup, R.A, Mascola, J.R, Floris-Moore, M, Ferrari, G, Eron, J.J, Kuruc, J.D, Archin, N.M, Gay, C.L

Volltext

PP 10.0 - Induction of HIV from latency by a novel molecule von Archin, N.M., Boden, D., Kirchherr, J., Allard, B., Sholtis, K., Kuruc, J.D., Kraus, G., Margolis, D.M.

Volltext